ORAGENICS INC Cash Flow Statement
OGEN|12 years of annual SEC 10-K data (FY2011-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 12 fiscal years. All figures from audited SEC 10-K filings.
ORAGENICS INC used $9M in operating cash flow in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$10.6M | -$14.3M | -$15.7M | -$15.7M | -$9.9M | -$7.0M | -$11.7M | -$5.8M | -$5.8M | -$13.1M | -$13.1M | -$7.8M |
| Depreciation & Amortization | - | $44.7K | $41.2K | $41.2K | $30.1K | $75.0K | $71.2K | $27.7K | $27.7K | $75.2K | $75.2K | $42.7K |
| Operating Cash Flow | -$8.6M | -$15.2M | -$13.5M | -$13.5M | -$9.1M | -$7.1M | -$5.2M | -$5.6M | -$5.6M | -$5.2M | -$5.2M | -$6.4M |
| Capital Expenditures | - | $127.5K | $43.9K | $43.9K | $124.7K | $27.2K | $102.5K | $110.7K | $110.7K | $11.1K | $11.1K | $88.1K |
| Free Cash Flow | - | -$15.4M | -$13.5M | -$13.5M | -$9.2M | -$7.1M | -$5.3M | -$5.7M | -$5.7M | -$5.2M | -$5.2M | -$6.5M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | $3.8K |
| FCF Margin | - | -11675.7% | -15535.8% | -15535.8% | - | - | - | -603.2% | -2641.3% | -392.2% | -392.2% | -499.4% |